Clinical Trials Logo

Stress clinical trials

View clinical trials related to Stress.

Filter by:

NCT ID: NCT01446588 Withdrawn - Depression Clinical Trials

Ocular Hypertension And Yoga Study

OHAYS
Start date: June 2012
Phase: N/A
Study type: Interventional

The investigators aim to pilot test the efficacy of a yoga intervention designed specifically for individuals with ocular hypertension. The investigators would like to find out if a combination of breathing, postures and meditation may help to reduce intraocular pressure in the short term after each yoga session, and also long-term across an 8-week program. Subjects will participate in the yoga intervention sessions led by Dr. Pamela Jeter once a week at the investigators center, and will be asked to practice at home at least twice a week using a audio CD.

NCT ID: NCT00429117 Withdrawn - Stress Clinical Trials

Interest in Spirituality and Oncology: Is It An International Phenomenon?

Start date: January 2007
Phase: N/A
Study type: Observational

Primary Objective: -To assess correlations between spiritual and religious beliefs and physician burnout using the Work Related Stress Inventory. Secondary Objectives: - To assess relationships between a physician's spiritual/religious beliefs and age, race, sex, marital status, and nationality. - To explore differences in survey responses among oncologists from different countries: Duke University Religion Index (DUREL), Hoge (Intrinsic religiosity scale), Templer's Death Anxiety Scale, Locus of Control Scale, Work Related Strain Inventory, and non-validated case scenarios. - To correlate survey responses to management of specific patient case situations.

NCT ID: NCT00375531 Withdrawn - Stress Clinical Trials

Use of Mindfulness Meditation With Iraqi/Afghanistan War Veterans

Start date: October 2006
Phase: N/A
Study type: Interventional

Objectives: The primary objective of this study is to conduct a randomized pilot study on the efficacy of Mindfulness Meditation (MfM) on sleep in post war Iraqi/Afghanistan veterans with PTSD. It is hypothesized that the change in sleep (measured by actigraphy), sleep self report measures, and PTSD symptoms (measured by the PTSD Checklist) from baseline, 8 weeks and 12 weeks will be greater for veterans with PTSD who are treated with MfM, controlling for pretreatment values and other clinical and demographic factors. A secondary objective will investigate whether there is an improvement in psychological wellness (measured by optimism, perceived wellness, and spirituality) following MfM treatments. It is hypothesized that change in optimism, perceived wellness, and spirituality from baseline, 8 weeks and 12 weeks will improve in veterans with PTSD who are treated with MfM, controlling for pretreatment values and other clinical and demographic factors. Physiological measures of actigraphy in the home will be done at baseline, eight weeks, and twelve weeks. Subjective measure of sleep include measurements of sleep and quality of life(FOSQ) and subjective sleep quality (PSQI). Other self-report measures that will examine psychological wellness include the Life Orientation Test (LOT), the Perceived Wellness Survey (PWS) and the Spirituality Assessment Scale (SAS).